Analysis of the progression of intraductal proliferative lesions in the breast by PCR-based clonal assay

Breast Cancer Research and Treatment
Qi YuYuRong Shi

Abstract

To analyze the progression in patients with a morphological diagnosis of intraductal proliferative lesions by PCR-based clonal assay. An X-chromosome inactivation assay was applied to explore clonal relationships in human intraductal proliferative lesions of the breast. Four groups samples, including 40 cases of usual ductal hyperplasia (UDH), 40 cases of atypical ductal hyperplasia (ADH), 29 cases of flat epithelia atypia (FEA), and 40 cases of ductal carcinoma in situ (DCIS) were selected for analysis. Thirty specimens of normal breast tissue were used as a control group. Microdissection was performed to collect the tissue samples for extraction of genomic DNA from paraffin-embedded tissues. The DNA was subjected to PCR amplification of the CAG repeats in androgen receptor (AR) gene exon I with and without prior digestion of methylation-sensitive restriction enzyme HhaI. Gel electrophoresis was used to detect the clonal nature of these four groups samples. The clonal analysis confirmed monoclonality in all informative samples of DCIS cells. Normal tissues and the majority (97.1%) of UDH were shown to be polyclonal. Monoclonality was revealed in 20/39 (51.3%) cases of ADH. Among 26 cases of FEA, 20 were shown to be polyclonal,...Continue Reading

References

Jan 17, 1985·The New England Journal of Medicine·W D Dupont, D L Page
Mar 8, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T OchiaiT Ashihara
Dec 8, 2000·Steroids·A GompelW Rostène
Mar 22, 2001·Histopathology·Y EndohT Motoyama
Mar 30, 2001·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·S J Diaz-CanoH J Wolfe
Dec 6, 2001·Journal of the National Cancer Institute·M R WrenschM Rhys
Mar 27, 2002·The American Journal of Surgical Pathology·A M ShaabanC S Foster
Sep 5, 2002·The Journal of Pathology·Arno KuijperPaul J van Diest
Oct 29, 2003·Breast Cancer Research : BCR·Jorge S Reis-Filho, Sunil R Lakhani
Apr 15, 2004·Journal of Mammary Gland Biology and Neoplasia·Elizabeth Anderson, Robert B Clarke
Jun 16, 2004·Cancer·E Shelley HwangFrederic M Waldman
Aug 7, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·E Shelley HwangFrederic M Waldman
Jan 11, 2005·The Journal of Pathology·Peter T SimpsonSunil R Lakhani
Mar 17, 2005·Breast Cancer Research and Treatment·Claudio Di CristofanoAndrea Cavazzana
May 18, 2005·The American Journal of Surgical Pathology·Peter T SimpsonSunil R Lakhani
Jul 22, 2005·The New England Journal of Medicine·Lynn C HartmannDaniel W Visscher
Oct 26, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Timothy D JonesLiang Cheng
Jan 10, 2006·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·David J DabbsSidney Finkelstein
Oct 24, 2006·Virchows Archiv : an International Journal of Pathology·Mohiedean GhofraniFattaneh A Tavassoli
Nov 11, 2006·Human Pathology·Lakshmi P Kunju, Celina G Kleer
Jun 15, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Amy C DegnimLynn C Hartmann
Jul 11, 2007·The Journal of Molecular Diagnostics : JMD·Evgeny YakirevichMurray B Resnick
Sep 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maria J WorshamSandra R Wolman

❮ Previous
Next ❯

Citations

Nov 10, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Megan L TroxellChristopher L Corless
Sep 16, 2017·Breast Cancer Research and Treatment·David N Danforth

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.